|
Plexiglas® Acrylic Molding Resin
Current Device Master Files for Clear Plexiglas® Resins At FDA
| Plexiglas® DR-100 |
Plexiglas® HFI10G-100 |
Plexiglas® VS-100 |
| Plexiglas® DR-101 |
Plexiglas® MI7-100 |
Plexiglas® VM-100 |
| Plexiglas® DRG-100 |
Plexiglas® MI7G-100 |
Plexiglas® V825-100 |
| Plexiglas® HFI7-100 |
Plexiglas® SG7-101 |
Plexiglas® V920-100 |
| Plexiglas® HFI7G-100 |
Plexiglas® SG10-101 |
Altuglas® 327 |
| Plexiglas® HFI10-100 |
Plexiglas® V052-100 |
|
USP Class VI Testing Completed
| Plexiglas® DR-100 |
Plexiglas® HFI7G-100 |
Plexiglas® SG7-101 |
| Plexiglas® DR-101 |
Plexiglas® HFI10-100 |
Plexiglas® SG10-101 |
| Plexiglas® DR-66021 |
Plexiglas® HFI10G-100 |
Plexiglas® V052-100 |
| Plexiglas® DRG-100 |
Plexiglas® MI7-100 |
|
| Plexiglas® HFI7-100 |
Plexiglas® MI7G-100 |
| Hemolysis Testing Completed
| Plexiglas® DR-100 |
Plexiglas® DRG-100 |
Plexiglas® SG7-101 |
| Plexiglas® DR-101 |
Plexiglas® HFI10G-100 |
Plexiglas® SG10-101 |
| Plexiglas® DR-66021 |
Plexiglas® MI7-100 |
|
Cytotoxicity Testing Completed
| Plexiglas® DR-100 |
Plexiglas® SG7-101 |
| Plexiglas® DR-101 |
Plexiglas® SG10-101 | Altuglas International does not recommend the use of any of our products for medical implantation devices. We have done no testing that would support the use of our products for medical implantation devices and based on our lack of supportive data, have decided not to pursue or support this segment of the medical market. This policy does not apply to non-implantation medical devices.
|